The effect of excess length of double J stent on stent related symptoms

Authors

  • Chaowat Pimratana Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • Teerapon Amornvesukit Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Keywords:

Double J stent, Stent-related symptoms

Abstract

Objective: To evaluate the relation between the excess length of double J stent on urinary symptoms and pain in patients who indwelling double J stent.

Method: A total of 41 patients, who had opted for management with insertion of a 6 F double J ureteral stent after stone management and undergone intravenous pyelography or retrograde pyelography before procedure, were prospectively observed. Tolerance to the indwelling double J stent was assessed using a urinary symptom questionnaire and pain score at 2 weeks after placement.

Results: The urinary symptoms varied from 6 to 27 with mean of 15.1 (SD=4.4) and median of 16. Plot of excess length of double J stent against urinary symptoms revealed a positive correlation with Spearman r of 0.506 (p=0.001). The mean excess length of double J stent which causing significant symptom score was 4.3 cm. The excess length of double J stent against pain score showed a positive correlation with Spearman r of 0.353 (p=0.023).

Conclusions: The excess length of double J stent, measured from imaging ureteral length, was positive correlation to urinary symptoms. The urinary symptoms were significant when excess length of double J stent more than 4.3 cm. The ureteral length from imaging may be helpful for stent selection to reduce stent related symptoms

Downloads

Download data is not yet available.

References

Lawrentschuk N, Russell JM. Ureteric stenting 25 years on: Routine or risky? ANZ J Surg 2004; 74: 243-7.

Duvdevani M, Chew BH, Denstedt JD. Minimizing symptoms in patients with ureteric stents. Curr Opin Urol 2006; 16: 77-82.

Deliveliotis C, Chrisofos M, Gougousis E, Papatsoris A, Dellis A, Varkarakis IM. Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology 2006; 6: 35-9.

Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG, Barry MJ. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 2003; 169: 1065-9.

JoshiHB,NewnsN,StainthorpeA,MacDonaghRP,KeeleyFXJr,TimoneyAG.Ureteralstentsymptomquestionnaire:development and validation of a multidimensional quality of life measure. J Urol 2003; 169: 1060-4.

Yachia D, Paterson PJ. Stenting the urinary system, 2nd ed. Hampshire, Thomson Publishing Services; 2004: 271-84.

Pilcher JM, Patel U. Choosing the correct length of ureteric stent: A formula based on the patientûs height compared with direct ureteric measurement. Clinical radiology 2002; 57: 59-62.

Chew BH, Knudsen BE, Denstedt JD. The use of stents in contemporary urology. Curr Opin Urol 2004; 14: 111-5.

Downloads

Published

2008-06-01

How to Cite

Pimratana, C., & Amornvesukit, T. (2008). The effect of excess length of double J stent on stent related symptoms. Insight Urology, 29(1), 20–25. Retrieved from https://he02.tci-thaijo.org/index.php/TJU/article/view/253006

Issue

Section

Original article

Most read articles by the same author(s)

> >>